Back to the future: a recent history of haemophilia treatment
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary. In the last few decades, the management of patients with haemophilia has witnessed dramatic improvements, through the larger availability of safe plasma‐derived and recombinant products for replacement therapy. Another important step forward is the progressively larger‐scale implementation of primary prophylaxis in children. Currently, the main problem in patients with haemophilia is the onset of antibodies inactivating the infused clotting factor (inhibitors), even though immune tolerance regimens that are able to eradicate inhibitors and the availability of products that bypass the intrinsic coagulation defects have dramatically improved the management of these patients. Cure of haemophilia through gene transfer is being attempted, but relatively, it is far from being implemented on a large scale. It is likely that further improvements in replacement therapy will occur in the near future, through the availability of new‐therapeutic tools such as factors VIII and IX with longer half‐lives, more potent bypassing agents and factors extracted from the milk of transgenic animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Manco-Johnson, M. J., Abshire, T. C., Shapiro, A. D., Riske, B., Hacker, M. R., Kilcoyne, R., Ingram, J. D., Manco-Johnson, M. L., Funk, S., Jacobson, L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067659 · Cited by 1,950
Lusher, J. M., Arkin, S., Abildgaard, C. F., & Schwartz, R. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280701 · Cited by 476
Cited by
Continuing Education Course #2: Current Understanding of Hemostasis
Gale, A. J. (2011) · Toxicologic Pathology · doi:10.1177/0192623310389474 · Cited by 376
Past, present and future of hemophilia: a narrative review
Franchini, M., & Mannucci, P. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-24 · Cited by 281
Self-citationKannicht, C., Ramström, M., Kohla, G., Tiemeyer, M., Casademunt, E., Walter, O., & Sandberg, H. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.011 · Cited by 120
Improved expression of recombinant human factor IX by co-expression of GGCX, VKOR and furin
Liu, J., Jonebring, A., Hagström, J., Nyström, A.-C., & Lövgren, A. (2014) · The Protein Journal · doi:10.1007/s10930-014-9550-5 · Cited by 20
Metadata
- Authors
- MANNUCCI, P. M.
- Venue
- Haemophilia
- Publisher
- Wiley
- Published
- 2008-05-16
- Volume
- 14
- Issue
- s3
- Pages
- 10-18
- ISSN
- 1351-8216 (ISSN-L)
- 1365-2516
- OpenAlex
- W2011753037
- Cited by
- 175
- References
- 3
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Back to the future: a recent history of haemophilia treatment. https://app.cochat.ai/papers/10.1111/j.1365-2516.2008.01708.x
- The paper
- MANNUCCI, P. M. (2008). Back to the future: a recent history of haemophilia treatment. Haemophilia. https://doi.org/10.1111/j.1365-2516.2008.01708.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.